1,2,6-Triazaspiro[2.5]oct-1-ene hydrochloride, 97%, 1g

2,3-Dinitroaniline, 95.0%, 1g

6-Methoxybenzo[d]isoxazol-3-amine, 98%, 5g

3-(DIBUTYLAMINO)PROPYL 4-HYDROXYBENZOATE (HCL), 95%, 1g

N-methyl-6-(2,2,2-trifluoroethoxy)-1,3,5-triazine-2,4-diamine, 95.0%, 1g

Methyl 1-(pyridin-4-yl)cyclopropanecarboxylate, 95.0%, 250mg

Cobalt(II) perchlorate hexahydrate, = 99%, 1g

Ethyl 3-(N-butyl-3-methylbenzamido)propanoate, 97%, 100mg

1-METHYL-4-(3-NITROPYRIDIN-2-YL)PIPERAZINE, 97.0%, 1g

1,4-Dioxane, min. 99.5%, for synthesis, stabilized, 2.5 l, glass packaging

4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-amine, 98%, 100mg

Erucic Acid>85.0%(GC)400g

anti-p16 Protein mouse monoclonal, DCS-50, 0.2 ml